Feds Producing More Marijuana For Medical Research

The federal government recently announced it will be producing more marijuana for medical research, specifically the Drug Enforcement Agency (DEA). They stated production yields will be increased from a targeted 21 kilograms to 650 kilograms (roughly 1,443 pounds). Clinical researchers have been calling for an increase demand as the only place they can legally obtain marijuana is through the federal government, from one farm, which exists on the campus of the University of Mississippi.

The best delta 8 carts 2021 are available at the online platform to benefit theconsumers. According to the research, you can pick the right products with the skills to have the desired results available. Ensure that there is compliance of the federal laws and other governance for the purpose. 

Any university or private research facility is required permission from four federal bureaus; the Food and Drug Administration, the DEA, the U.S. National Institute of Drug Abuse and the Public Health Service (PHS), in order to run clinical trials on human test subjects. On many occasions, researchers have publicly denounced the federal government for throwing up road blocks, endless red time and blockage of clinical marijuana trials. Marijuana is the only drug that requires special federal permission to study.

In March the University of Arizona was finally permitted to do a medical marijuana study, this time to see what effects it has in calming post-traumatic stress disorder (PTSD) on military veterans. Surprisingly, several conservative states like Kentucky, Florida, Alabama, and Wisconsin are allowing testing on the therapeutic properties of cannabidoil (CBD), a non-psychotropic cannabinoid or compound found in marijuana plants. A new low THC strain of marijuana was created in Colorado called “Charlotte’s Web”, named for the little girl it saved from hundreds of daily epileptic seizures.

A government spokesman recently told, “The additional supply [of cannabis] to be manufactured in 2014 is designed to meet the current and anticipated research efforts involving marijuana. This projection of increased demand is due in part to the recent increased interest in the possible therapeutic uses of marijuana.” Traditionally the federal government only allowed research done on marijuana to prove it’s averse health effects in an effort to cull usable facts for the War on Drugs. Today, because of the dramatic results some patients have claimed to have, the federal government is finally allowing clinical trials to move forward, putting to rest the fact that marijuana has medicinal value once and for all.

Eric Desiree is a graduate of Bachelor of Arts in Communication. He started his career as a Public Relations Officer in a law firm in Los Angeles California. Currently, he is the managing editor of ANCPR.